Harald Kugel

Harald Kugel

Auto-generated profile, based on publicly available information

Harald Kugel

University Clinic for Radiology, University of Münster, Münster, Germany

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2016 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
LSLianne Schmaal
Lianne Schmaal
DHD P Hibar
D P Hibar
PSP G Sämann
P G Sämann
GHG B Hall
G B Hall
BBB T Baune
B T Baune
DVD J Veltman
D J Veltman
The neuro-anatomical substrates of major depressive disorder (MDD) are still not well understood, despite many neuroimaging studies over the past few decades. Here we present the largest ever worldwide study by the ENIGMA (Enhancing Neuro Imaging Genetics through Meta-Analysis) Major Depressive Disorder Working Group on cortical structural alterations in MDD. Structural T1-weighted brain magnetic resonance imaging (MRI) scans from 2148 MDD patients and 7957 healthy controls were analysed with harmonized protocols at 20 sites around the world. To detect consistent effects of MDD and its modulators on cortical thickness and surface area estimates derived from MRI, statistical effects from sites were meta-analysed separately for adults and adolescents. Adults with MDD had thinner cortical gray matter than controls in the orbitofrontal cortex (OFC), anterior and posterior cingulate, insula and temporal lobes (Cohen’s d effect sizes: −0.10 to −0.14). These effects were most pronounced in first episode and adult-onset patients (>21 years). Compared to matched controls, adolescents with MDD had lower total surface area (but no differences in cortical thickness) and regional reductions in frontal regions (medial OFC and superior frontal gyrus) and primary and higher-order visual, somatosensory and motor areas (d: −0.26 to −0.57). The strongest effects were found in recurrent adolescent patients. This highly powered global effort to identify consistent brain abnormalities showed widespread cortical alterations in MDD patients as compared to controls and suggests that MDD may impact brain structure in a highly dynamic way, with different patterns of alterations at different stages of life.

1 February 2012 in Biological Psychiatry
Verified
Journal Article
Closed access
UDUdo Dannlowski
Udo Dannlowski
ASAnja Stuhrmann
Anja Stuhrmann
VBVictoria Beutelmann
Victoria Beutelmann
PZPeter Zwanzger
Peter Zwanzger
TLThomas Lenzen
Thomas Lenzen
HKHarald Kugel
Harald Kugel

2 May 2017 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
DHD P Hibar
D P Hibar
LWL T Westlye
L T Westlye
NDN T Doan
N T Doan
NJN Jahanshad
N Jahanshad
JCJ W Cheung
J W Cheung
OAO A Andreassen
O A Andreassen
Despite decades of research, the pathophysiology of bipolar disorder (BD) is still not well understood. Structural brain differences have been associated with BD, but results from neuroimaging studies have been inconsistent. To address this, we performed the largest study to date of cortical gray matter thickness and surface area measures from brain magnetic resonance imaging scans of 6503 individuals including 1837 unrelated adults with BD and 2582 unrelated healthy controls for group differences while also examining the effects of commonly prescribed medications, age of illness onset, history of psychosis, mood state, age and sex differences on cortical regions. In BD, cortical gray matter was thinner in frontal, temporal and parietal regions of both brain hemispheres. BD had the strongest effects on left pars opercularis (Cohen’s d=−0.293; P=1.71 × 10−21), left fusiform gyrus (d=−0.288; P=8.25 × 10−21) and left rostral middle frontal cortex (d=−0.276; P=2.99 × 10−19). Longer duration of illness (after accounting for age at the time of scanning) was associated with reduced cortical thickness in frontal, medial parietal and occipital regions. We found that several commonly prescribed medications, including lithium, antiepileptic and antipsychotic treatment showed significant associations with cortical thickness and surface area, even after accounting for patients who received multiple medications. We found evidence of reduced cortical surface area associated with a history of psychosis but no associations with mood state at the time of scanning. Our analysis revealed previously undetected associations and provides an extensive analysis of potential confounding variables in neuroimaging studies of BD.

1 January 2010 in Biological Psychiatry
Verified
Journal Article
Closed access
TSThomas Suslow
Thomas Suslow
CKCarsten Konrad
Carsten Konrad
HKHarald Kugel
Harald Kugel
DRDaniel Rumstadt
Daniel Rumstadt
PZPienie Zwitserlood
Pienie Zwitserlood
UDUdo Dannlowski
Udo Dannlowski

1 June 2016 in JAMA Psychiatry
Verified
Journal Article
Closed access
PDF file
RRRonny Redlich
Ronny Redlich
NONils Opel
Nils Opel
DGDominik Grotegerd
Dominik Grotegerd
KDKatharina Dohm
Katharina Dohm
DZDario Zaremba
Dario Zaremba
UDUdo Dannlowski
Udo Dannlowski
Research from JAMA Psychiatry — Prediction of Individual Response to Electroconvulsive Therapy via Machine Learning on Structural Magnetic Resonance Imaging Data

1 November 2014 in JAMA Psychiatry
Verified
Journal Article
Open access
PDF file
RRRonny Redlich
Ronny Redlich
JAJorge J. R. Almeida
Jorge J. R. Almeida
DGDominik Grotegerd
Dominik Grotegerd
NONils Opel
Nils Opel
HKHarald Kugel
Harald Kugel
UDUdo Dannlowski
Udo Dannlowski
Unipolar depression (UD) and bipolar disorders are leading causes of disability worldwide.1,2 Among patients with bipolar disorder, misdiagnosis rates of up to 75% are reported, primarily for UD,3,4 leading to insufficient treatment, poor outcome, and higher health care costs.5,6 There is a particular difficulty in distinguishing bipolar depression (BD) from UD, owing to their having the same diagnostic criteria for a depressive episode; the higher prevalence of depressive symptoms, rather than hypomanic symptoms, in bipolar disorder; and the presence of subthreshold manic symptoms for both disorders during a depressive episode.7,8 A major research goal is thus to identify neurobiological markers that can help differentiate these disorders, especially for individuals presenting during depressive episodes.